SYNOPSIS: This study determined that buffered crystalloid did not reduce risks of acute kidney injury among crystalloid fluid therapy patients in the ICU.

SYNOPSIS: This meta-analysis demonstrates that despite no strategy to alleviate blood pressure actually prolonging the lives of diabetic patients with kidney disease, angiotensin-receptor blockers and angiotensin-converting enzyme, whether administered alone or in some combination, appear to be the most efficacious strategies in the prevention of end-stage renal disease.